NeoGenomics (NEO) Ownership - Who Owns NeoGenomics?
NeoGenomics (NEO) Ownership Overview
- 0.82% Insiders
- 29.68% Mutual Funds
- 0.81% Other Institutional Investors
- 33.09% ETFs
- 35.59% Public Companies and Individual Investors
The ownership structure of NeoGenomics (MX:NEO) stock is a mix of institutional, retail, and individual investors. Approximately 63.58% of the company’s stock is owned by Institutional Investors, 0.82% is owned by Insiders, and 35.59% is owned by Public Companies and Individual Investors.
The ownership structure of NeoGenomics (MX:NEO) stock is a mix of institutional, retail, and individual investors. Approximately 63.58% of the company’s stock is owned by Institutional Investors, 0.82% is owned by Insiders, and 35.59% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Aug 05, 2026 | Greg Aunan | $321,400 | |
| Jun 16, 2026 | Lynn Tetrault | $58,908 | |
| Jun 10, 2026 | Lynn Tetrault | $59,916 | |
| Jan 20, 2026 | Warren Stone | $276,600 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Ishares | 14,534,058 | Institution | 11.23% | 262,267,077 |
| Vanguard | 12,100,458 | Institution | 9.35% | 218,352,765 |
| Delaware Group Equity Funds V | 10,775,704 | Institution | 8.33% | 194,447,579 |
| Vanguard Index Funds | 10,321,832 | Institution | 7.98% | 186,257,458 |
| First Trust | 6,768,086 | Institution | 5.23% | 122,130,112 |
| Spdr | 2,633,133 | Institution | 2.04% | 47,514,885 |
| Steve Weber | 2,508,845 | Institution | 1.94% | 45,272,108 |
| Invesco | 2,082,303 | Institution | 1.61% | 37,575,158 |
| Fidelity Salem Street Trust | 1,638,180 | Institution | 1.27% | 29,560,958 |
| Dfa | 1,434,348 | Institution | 1.11% | 25,882,810 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Delaware Group Equity Funds V | 10,775,704 | Institution | 8.33% | 194,447,579 |
| Vanguard Index Funds | 10,321,832 | Institution | 7.98% | 186,257,458 |
| Fidelity Salem Street Trust | 1,638,180 | Institution | 1.27% | 29,560,958 |
| Loomis Sayles Funds Ii | 1,379,712 | Institution | 1.07% | 24,896,903 |
| Fidelity Concord Street Trust | 1,310,737 | Institution | 1.01% | 23,652,249 |
| Dfa Investment Dimensions Group Inc | 1,114,373 | Institution | 0.86% | 20,108,861 |
| Glenmede Fund Inc | 1,027,172 | Institution | 0.79% | 18,535,319 |
| Vanguard Tax-managed Funds | 912,240 | Institution | 0.71% | 16,461,371 |
| Vanguard Scottsdale Funds | 890,765 | Institution | 0.69% | 16,073,854 |
| Alger Funds | 717,731 | Institution | 0.55% | 12,951,456 |
FAQ
Who Owns NeoGenomics (MX:NEO)?
According to the latest TipRanks data, approximately 63.58% of the company's stock is held by institutional investors, 0.82% is held by insiders, and 35.59% is held by public companies and individual investors.
What percentage of NeoGenomics (MX:NEO) stock is held by institutional investors?
According to the latest TipRanks data, approximately 63.58% of NeoGenomics (MX:NEO) stock is held by institutional investors: 29.68% by mutual funds, 33.09% by ETFs and 0.81% by other institutional investors.
What percentage of NeoGenomics (MX:NEO) stock is held by retail investors?
According to the latest TipRanks data, approximately 35.59% of NeoGenomics (MX:NEO) stock is held by public companies and individual investors.
Who owns the most shares of NeoGenomics (MX:NEO)?
iShares owns the most shares of NeoGenomics (MX:NEO).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.